Concepedia

C.A. Jennings

CJ

13

Publications

440

Citations

13

H-Index

1984

Active since

Affiliations

National Institute for Biological Standards and Control(Current)

GlaxoSmithKline (United Kingdom)

Merck & Co., Inc., Rahway, NJ, USA (United States)

C.A. Jennings is an author at National Institute for Biological Standards and Control specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1984–2008

13

Publications

13

Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects

N.M.J. Rupniak, M. J. Steventon, Mark J. Field et al. · Psychopharmacology · 1989 · 71 citations

, , +12

Inhibition of the tissue factor-factor vii complex: involvement of factor xa and lipoproteins

A. R. Hubbard, C.A. Jennings · Thrombosis Research · 1987 · 67 citations

, , +8

Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat

Marie L. Woolley, Kerry A. Waters, Jane Gartlon et al. · Psychopharmacology · 2008 · 46 citations

, , +10

The distribution of the orphan bombesin receptor subtype-3 in the rat cns

C.A. Jennings, David C. Harrison, Peter R. Maycox et al. · Neuroscience · 2003 · 44 citations

, , +8

Neutralisation of Heparan Sulphate and Low Molecular Weight Heparin by Protamine

A. R. Hubbard, C.A. Jennings · Thrombosis and Haemostasis · 1985 · 37 citations

, , +16

Rows per page

1–5 of 13